← Ишга қайтиш
Ушбу иш иқтибос қилган ишлар
159 та иш
Иш: PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén +25
Мақола20172 иқтибосABIEfficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean‐Claude Tardif, Simon Kouz, David D. Waters +22
Мақола20192 иқтибосABITwo Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend +8
Мақола20202 иқтибосABIColchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd +30
Мақола20202 иқтибосABIPCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci, Massimiliano Ruscica, Marina Camera +10
Мақола20182 иқтибосABIRole of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Paolo Raggi, Jacques Genest, Jon T. Giles +4
Шарҳ мақола20182 иқтибосABIPCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi‐Borojeni, Sarvenaz Sabouri-Rad, Antonio M. Gotto +5
Шарҳ мақола20192 иқтибосABIThe role of long noncoding RNA in major human disease
Xiaoli Zhang, Ruiyun Hong, Weiqiang Chen +2
Шарҳ мақола20192 иқтибосABIProprotein Convertase Subtilisin/Kexin Type 9
Chiara Macchi, Nicola Ferri, Cesare R. Sirtori +3
Шарҳ мақола20212 иқтибосABITargeting inflammation in atherosclerosis — from experimental insights to the clinic
Шарҳ мақола20212 иқтибосABIHow the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Payel Roy, Marco Orecchioni, Klaus Ley
Шарҳ мақола20212 иқтибосABIPCSK9-targeted therapies: present and future approaches
Mahmoud Al Rifai, Christie M. Ballantyne
Шарҳ мақола20212 иқтибосABIInflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang +3
Шарҳ мақола20222 иқтибосABI